Menu
Back to Journals
International Medical Case Reports Journal
ISSN: 1179-142X
Professor Ronald Prineas
Section: Case Reports
Professor Prineas
Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Professor Ronald Prineas MB BS (University of Sydney/Australia) PhD (University of London/UK) FACE, FACC, FAHA, FRCP (Lond), FRCPE, Professor Emeritus Division of Public Health Sciences, Wake Forest University School of Medicine. He was director of EPICARE section of Epidemiology and Prevention, Division of Public Health Sciences until retirement in 2009; Chair of the Department of Epidemiology and Public Health at the University of Miami, Florida from 1988 to 1997. Before that, he was on the faculty at the University of Minnesota, Minneapolis; at the University of Melbourne, Australia; the London School of Hygiene and Tropical Medicine, London UK; and clinical resident at the Royal Infirmary in Glasgow, Scotland; Royal Perth Hospital, Western Australia; and the Royal Prince Henry Hospital, Sydney Australia. He has continued experience in cardiovascular disease clinical trials and epidemiological studies particularly with population electrocardiology and blood pressure methodology.
He is the senior author of the Minnesota Code Manual of Electrocardiographic Findings; and has authored over 400 peer-reviewed scientific publications. He has extensive experience as PI, chair and member of all committees (including data and safety monitoring committees) related to clinical trials and longitudinal epidemiologic studies related to coronary heart disease, hypertension and diabetes (among children, adults and the aged) conducted by NIH, over the past 35 years, and latterly has been an investigator in international clinical trials among HIV infected adults. He is a continuing consultant to WHO and NHANES on matters of survey methodology and is currently a consultant to the i3C follow up study; and continues to serve on adjudication committees for a number of national and international clinical trials; and classifies electrocardiograms for several clinical trials; and serves as editor on a number of online Public Health journals.
Dr Vinay Kumar
Section: Case Reports
Dr Kumar
Heart and Vascular Institute, Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA
Dr. Vinay Kumar holds a master's degree in biotechnology from Himachal Pradesh University, Shimla, India, as well as a PhD in Molecular Biology and Genetic Engineering from Jawaharlal Nehru University, New Delhi, India. Presently at Pennsylvania State University, he conducts thorough studies of dysregulated innate and adaptive immunological networks and their function in modulating the pathophysiology of myocardial infarction (MI) and chronic heart failure (HF).
Dr. Kumar is especially interested in determining the function of T-cell subsets and the time-dependent phenotypic changes that these cells endure during chronic HF. In addition, he is interested in identifying and devising novel strategies to reverse pathological changes in immune cells in preparation for their transition from the laboratory to the clinic. His training in physiology, immunology, and molecular biology equips him with unique perspectives to research heart failure and develop mechanism-based, clinically applicable immune-therapeutic strategies.
Dr Xudong Zhu
Section: Case Reports
Dr Zhu
Markey Cancer Center, University of Kentucky, Lexington, KY, USA
Dr. Xudong Zhu obtained his BMed, M.D., and Ph.D. from China Medical University (Shenyang, China). Now, he is an Assistant Professor at the Cancer Hospital of Dalian University of Technology and a Post-doctoral Scholar at Markey Cancer Center of University of Kentucky.
His research is mainly focused on the pathogenesis of endocrinology-related diseases including endocrinology-related cancer, especially breast cancer, and gastroenterology-related disease including hepatocellular carcinoma, gastric carcinoma and others. He is also focused on screening and validating small molecular compounds which could effectively target and kill endocrinology-related and gastroenterology-related solid cancer cells.
Dr. Zhu has published more than 20 articles in peer-reviewed journals with a total impact factor of nearly 200. He is a regular peer reviewer for manuscripts submitted to SCI journals and is a member of the Editorial Board of 7 English journals.
Dr Scott Fraser
Section: Ophthalmology
Dr Fraser
Consultant Ophthalmologist, Sunderland Eye Infirmary, Sunderland, UK
Scott Fraser is a consultant ophthalmologist at Sunderland Eye Infirmary in the North East of the UK. He is also honorary lecturer at the University of Newcastle Upon Tyne and visiting professor at the University of Sunderland. He is a member of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists.
He trained as an ophthalmologist initially in Newcastle and then completed his training at Moorfields Eye Hospital. At Moorfields he was also a research fellow initially looking into risk factors for late presentation of glaucoma and later as the Friend of Moorfields funded researcher looking at the genetics of glaucoma. He was awarded his MD in 2000.
His main clinical interest is in glaucoma in which he completed subspeciality training at Moorfields. His research interests also include glaucoma but more widely he is interested in factors that alter compliance with eye medications. He also has an interest in evidence based medicine and is an editor for the Cochrane Eyes and Vision group. He has published over 50 peer reviewed articles and over 100 presentations at scientific meetings. He has written chapters for 7 textbooks and has co-written a manual for eye care.
Dr Taro Kishi
Section: Neuropsychiatric Disease and Treatment
Dr Kishi
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, he has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.
Dr Yuping Ning
Section: Neuropsychiatric Disease and Treatment
Dr Ning
Department of Psychiatry, Mental Health Institute of the Second Xiangya Hospital, Central South University, Guangzhou, China
Dr. Yuping Ning is director of the affiliated brain hospital of Guangzhou Medical University P.R.C. She is professor in neuropsychiatry and supervisor of PH.D students. She holds some positions such as member of Chinese Society of Psychiatry, Chairman of Guangdong Society of Psychiatry, member of standing committee of Guangdong Society of Neurology, etc. From 1986 to 1992, she educated in XiangYa Medical college and got MD degree there. From 1992 to 1997, she practiced psychiatry in Guangzhou Brain Hospital. From 1997 to 2003, she practiced and pursued her PHD in department of Neurology, Sun Yat-Sen medical university. Her research interests are in neurodegenerative diseases (AD and PD) and depression. As a visiting scholar, she performed genetic study in Parkinson disease in Juntendo University Japan. She has published 130 papers so far.
Dr Roger Pinder
Section: Neuropsychiatric Disease and Treatment
Dr Pinder
Pharma, Independent Pharma Consultant, York, UK
Roger M. Pinder, PhD, DSc is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).
Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.
After a long career in R&D and medical affairs management in the international pharmaceutical industry, Dr Pinder was associated with a number of start-up pharmaceutical companies as chairman, board member, advisor and consultant.
Editorial Board
Professor Shahin Akhondzadeh, Clinical Psychopharmacology, Tehran University of Medical Sciences, Tehran, Iran
Dr Ding
Dr Mengyuan Ding, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Professor Enkhbaatar
Professor Perenlei Enkhbaatar, Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA
Professor Filik
Professor Levent Filik, Gastroenterology Department, Ankara Research Hospital, Ankara, Turkey
Professor Kaplan
Professor Robert Kaplan, Clinical Excellence Research Center, Stanford University, Stanford, CA, USA
Prof. Dr. Katzman
Prof. Dr. Martin Katzman, START Clinic for the Mood and Anxiety Disorders, Toronto, Ontario, Canada
Dr Khan
Post-Doctoral Fellow, Erum Khan, Department of Neurology, The University of Alabama at Birmingham, Birmingham, AL, USA
Dr Kinderlehrer
Dr Daniel Kinderlehrer, MD, PC Private practice, Denver, CO, USA
Dr Kobets
Dr Andrew J. Kobets, Neurosurgical Director, Montefiore Craniofacial Center, Co-Director, Neurosurgical Oncology at the Children's Hospital at Montefiore, Assistant Professor of Neurological Surgery and Peditrics, Albert Einstein College of Medicine, Bronx, NY, USA
Dr Louis Sam Titus
Dr Anto Sam Crosslee Louis Sam Titus, Department of Biomedical Engineering, University of Houston, Houston, Texas, USA
Dr Mudalagiriyappa
Dr Srini Mudalagiriyappa, Amgen, Thousand Oaks, California, USA
Dr Ray
Dr Amit Ray, Neurology, Aurora Healthcare, Milwaukee, Wisconsin, USA
Professor Spigelman
Allan Spigelman, Professor of Surgery, University of New South Wales, Clinical, Sydney, Australia
Dr Uppal
Dr Dipan Uppal, Cleveland Clinic Florida, Ft. Lauderdale, Florida, USA